Lindbrook Capital’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $7.53K | Buy |
257
+94
| +58% | +$2.75K | ﹤0.01% | 1777 |
|
2024
Q4 | $5.36K | Hold |
163
| – | – | ﹤0.01% | 1950 |
|
2024
Q3 | $7.24K | Sell |
163
-14
| -8% | -$622 | ﹤0.01% | 1839 |
|
2024
Q2 | $7.63K | Buy |
177
+30
| +20% | +$1.29K | ﹤0.01% | 1782 |
|
2024
Q1 | $4.3K | Hold |
147
| – | – | ﹤0.01% | 1958 |
|
2023
Q4 | $3.27K | Sell |
147
-10
| -6% | -$223 | ﹤0.01% | 2087 |
|
2023
Q3 | $3.89K | Sell |
157
-74
| -32% | -$1.83K | ﹤0.01% | 1876 |
|
2023
Q2 | $6.54K | Buy |
231
+136
| +143% | +$3.85K | ﹤0.01% | 1680 |
|
2023
Q1 | $2.18K | Sell |
95
-54
| -36% | -$1.24K | ﹤0.01% | 2206 |
|
2022
Q4 | $4.18K | Buy |
149
+37
| +33% | +$1.04K | ﹤0.01% | 1912 |
|
2022
Q3 | $3K | Buy |
112
+38
| +51% | +$1.02K | ﹤0.01% | 1829 |
|
2022
Q2 | $2K | Buy |
74
+63
| +573% | +$1.7K | ﹤0.01% | 1894 |
|
2022
Q1 | $0 | Sell |
11
-85
| -89% | – | ﹤0.01% | 2462 |
|
2021
Q4 | $3K | Sell |
96
-39
| -29% | -$1.22K | ﹤0.01% | 1631 |
|
2021
Q3 | $6K | Hold |
135
| – | – | ﹤0.01% | 1162 |
|
2021
Q2 | $7K | Hold |
135
| – | – | ﹤0.01% | 1169 |
|
2021
Q1 | $7K | Hold |
135
| – | – | ﹤0.01% | 1130 |
|
2020
Q4 | $6K | Sell |
135
-52
| -28% | -$2.31K | ﹤0.01% | 1093 |
|
2020
Q3 | $7K | Hold |
187
| – | – | ﹤0.01% | 941 |
|
2020
Q2 | $10K | Buy |
187
+52
| +39% | +$2.78K | ﹤0.01% | 821 |
|
2020
Q1 | $5K | Hold |
135
| – | – | ﹤0.01% | 965 |
|
2019
Q4 | $6K | Buy |
+135
| New | +$6K | ﹤0.01% | 1044 |
|